X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with Dishman Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK LTD vs DISHMAN PHARMA - Comparison Results

MERCK LTD    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DISHMAN PHARMA 
   Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK LTD DISHMAN PHARMA MERCK LTD/
DISHMAN PHARMA
 
P/E (TTM) x 26.1 25.1 104.1% View Chart
P/BV x 2.9 3.3 87.3% View Chart
Dividend Yield % 1.0 0.7 145.7%  

Financials

 MERCK LTD   DISHMAN PHARMA
EQUITY SHARE DATA
    MERCK LTD
Dec-16
DISHMAN PHARMA
Mar-16
MERCK LTD/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs1,060374 283.1%   
Low Rs623129 483.3%   
Sales per share (Unadj.) Rs632.4197.8 319.7%  
Earnings per share (Unadj.) Rs45.721.2 215.6%  
Cash flow per share (Unadj.) Rs62.334.7 179.5%  
Dividends per share (Unadj.) Rs11.002.00 550.0%  
Dividend yield (eoy) %1.30.8 164.5%  
Book value per share (Unadj.) Rs388.8179.9 216.1%  
Shares outstanding (eoy) m16.6080.69 20.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.31.3 104.6%   
Avg P/E ratio x18.411.9 155.1%  
P/CF ratio (eoy) x13.57.2 186.3%  
Price / Book Value ratio x2.21.4 154.7%  
Dividend payout %24.19.4 255.1%   
Avg Mkt Cap Rs m13,96920,306 68.8%   
No. of employees `0001.60.8 191.0%   
Total wages/salary Rs m1,4875,355 27.8%   
Avg. sales/employee Rs Th6,631.919,252.7 34.4%   
Avg. wages/employee Rs Th939.26,459.5 14.5%   
Avg. net profit/employee Rs Th479.42,064.1 23.2%   
INCOME DATA
Net Sales Rs m10,49815,961 65.8%  
Other income Rs m242265 91.3%   
Total revenues Rs m10,74116,226 66.2%   
Gross profit Rs m1,1354,103 27.7%  
Depreciation Rs m2761,091 25.3%   
Interest Rs m0944 0.0%   
Profit before tax Rs m1,1022,334 47.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m01 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m343624 55.1%   
Profit after tax Rs m7591,711 44.4%  
Gross profit margin %10.825.7 42.1%  
Effective tax rate %31.126.7 116.6%   
Net profit margin %7.210.7 67.4%  
BALANCE SHEET DATA
Current assets Rs m6,41011,018 58.2%   
Current liabilities Rs m8,8289,517 92.8%   
Net working cap to sales %-23.09.4 -245.0%  
Current ratio x0.71.2 62.7%  
Inventory Days Days58110 52.2%  
Debtors Days Days3835 110.2%  
Net fixed assets Rs m1,40616,304 8.6%   
Share capital Rs m166161 102.9%   
"Free" reserves Rs m6,28612,907 48.7%   
Net worth Rs m6,45514,516 44.5%   
Long term debt Rs m04,189 0.0%   
Total assets Rs m8,82829,805 29.6%  
Interest coverage xNM3.5-  
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x1.20.5 222.1%   
Return on assets %8.68.9 96.5%  
Return on equity %11.811.8 99.7%  
Return on capital %17.117.5 97.4%  
Exports to sales %8.324.8 33.4%   
Imports to sales %21.03.7 563.2%   
Exports (fob) Rs m8693,956 22.0%   
Imports (cif) Rs m2,209596 370.5%   
Fx inflow Rs m9594,952 19.4%   
Fx outflow Rs m2,612697 374.9%   
Net fx Rs m-1,6534,255 -38.9%   
CASH FLOW
From Operations Rs m1,0702,786 38.4%  
From Investments Rs m-750-1,529 49.0%  
From Financial Activity Rs m-150-941 15.9%  
Net Cashflow Rs m171316 54.0%  

Share Holding

Indian Promoters % 0.0 61.4 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 18.2 3.7 491.9%  
FIIs % 1.0 12.7 7.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 22.1 131.7%  
Shareholders   28,591 46,261 61.8%  
Pledged promoter(s) holding % 0.0 35.8 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK LTD With:   GLENMARK PHARMA  FULFORD INDIA  DR. REDDYS LAB  DIVIS LABORATORIES  UNICHEM LAB  

Compare MERCK LTD With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Global Markets Remain Volatile Ahead of US Growth Concerns(RoundUp)

Benchmark indices in US corrected marginally by 0.8% during the week. Minutes of Federal Reserve's July meeting are out and the situation looks to be in favor of the emerging markets.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MERCK LTD SHARE PRICE


Aug 18, 2017 (Close)

TRACK MERCK LTD

  • Track your investment in MERCK LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MERCK LTD 8-QTR ANALYSIS

COMPARE MERCK LTD WITH

MARKET STATS